Dr. Katherine N. Weilbaecher, MD

  • Saint Louis, MO
  • Medical oncologist
NPI1447277942PAC ID2668506205
Medicare services, 2022
61
Part D claims, 2022
32
Publications
75
Clinical trials
8
MIPS score, 2024
84
Practice address
One Barnes-Jewish Hospital Plaza, Saint Louis, MO 63110
Practice phone
Call (314) 747-3000
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Barnes-Jewish Hospital

Hospital · Saint Louis, Missouri

See all 4 affiliations

Find Dr. Weilbaecher's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Katherine N. Weilbaecher is a medical oncologist in Saint Louis, Missouri

Dr. Weilbaecher practices at Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health.

Dr. Weilbaecher's NPI, 1447277942, was assigned on July 17, 2006. Dr. Weilbaecher graduated from Stanford University School of Medicine in 1992. Dr. Weilbaecher holds Missouri license 2000166707.

NPI and contact details
Medicare PAC ID
2668506205
NPI enumeration date
July 17, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(314) 747-3000
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Female
Estimated age
60
Medical school graduation
1992

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Katherine N. Weilbaecher practices at 2 locations in Saint Louis, Missouri

Dr. Weilbaecher's primary practice is Barnes-Jewish Hospital, at One Barnes-Jewish Hospital Plaza, Saint Louis, MO 63110 in St. Louis City. The practice phone is (314) 747-3000. Dr. Weilbaecher also practices at Barnes-Jewish Hospital, 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110.

  • Barnes-Jewish HospitalPrimary
    One Barnes-Jewish Hospital Plaza, Saint Louis, MO 63110 · St. Louis CityPhone(314) 747-3000
  • Barnes-Jewish Hospital
    1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110 · Saint Louis CityPhone(314) 747-3000

Sources: NPPES NPI Registry (CMS); Dmand AI Affiliation Data; and Dmand AI Practice Data

Dr. Katherine N. Weilbaecher is affiliated with 3 sites of care and 1 medical group

Dr. Weilbaecher's primary practice is Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health. Dr. Weilbaecher is also affiliated with Barnes-Jewish West County Hospital. The medical group on file is WashU Medicine Psychiatry. Dmand AI also links Dr. Weilbaecher to 1 more group practice or clinic, named with a free account.

See all 4 affiliations for Dr. Weilbaecher

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Katherine N. Weilbaecher's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Weilbaecher practices, 3 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Barnes-Jewish HospitalAvailable with a free account
+2 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Weilbaecher practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across BJC Health and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Katherine N. Weilbaecher is one of 120 medical oncologists in Missouri

Medical oncology is Dr. Weilbaecher's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Weilbaecher is licensed in Missouri.

Specialties and state licenses

  • Medical oncology, MissouriPrimaryLicense 2000166707 · taxonomy 207RX0202X

Medical oncologists near Dr. Weilbaecher

Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Katherine N. Weilbaecher billed Medicare for 61 services in 2022

CMS data shows 61 Medicare services from Dr. Weilbaecher across 2 procedure codes in 2022. Medicare paid $1,550 for them. Every service was in an office.

Medicare services, 202261
Paid by Medicare$1,550
Procedure codes2

Dr. Weilbaecher's Medicare services by type, 2021 to 2022

  • 2021
  • 2022
Surgery
2021: 722022: 3749%
Office and hospital visits
2021: 602022: 2460%

Dr. Weilbaecher compared with the Missouri median for medical oncologists, 2022

  • Dr. Weilbaecher
  • Missouri median
Medicare services
61vs 1,24695% below
Part D claims
32vs 56094% below

Medians across 125 medical oncologists in Missouri with Dmand AI profiles that report each measure.

Dr. Weilbaecher's most billed Medicare procedure codes, 2022

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Weilbaecher

Need commercial claims for Dr. Weilbaecher?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Weilbaecher and other medical oncologists in Missouri.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Katherine N. Weilbaecher's patients have a median age of 71

Across all payers, Dmand AI patient panel data puts Dr. Weilbaecher's median patient age at 71, with 84% women.

Dr. Weilbaecher's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 71

Patient panel by sex, all payers

  • Women84%
  • Men16%

Source: Dmand AI Patient Panel Data

Dr. Katherine N. Weilbaecher wrote 32 Medicare Part D claims in 2022

In 2022, Dr. Weilbaecher wrote 32 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $680 in total drug cost. In 2021, CMS named 54 claims across 3 drugs.

Part D claims, 202232
Drugs named by CMS1
Total drug cost$680

Dr. Weilbaecher's most prescribed drugs by claims, 2022

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Part D claims for drugs CMS names, 2021 to 2022

  • 2021
  • 2022
Claims for drugs CMS names
2021: 542022: 3241%

Drugs named by CMS: 1 in 2022, 3 in 2021.

See all prescribing by Dr. Weilbaecher

Source: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026

Dr. Katherine N. Weilbaecher scored 84 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Weilbaecher for performance year 2024, reported as part of a group. Dr. Weilbaecher accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Dr. Weilbaecher's MIPS scores, performance year 2024

  • 84of 100Final score
  • 71.6of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities
  • 76of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find medical oncologists like Dr. Weilbaecher by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Katherine N. Weilbaecher has 75 publications on record

Dmand AI links 75 papers to Dr. Weilbaecher, published from 2010 to 2024. 2021 was the busiest year, with 8. The most frequent topics are Breast Neoplasms, Bone Neoplasms and Cell Line, Tumor. Dr. Weilbaecher has published most often in Breast Cancer Res Treat. Dr. Weilbaecher's most frequent co-authors are Foluso Olabisi Ademuyiwa, MD, Lindsay Leuthen Peterson, MD and Rebecca L. Aft, MD.

Papers75
Years published2010 to 2024

Dr. Weilbaecher's papers by year, 2015 to 2024

Topics Dr. Weilbaecher writes about most

  • Breast Neoplasms
  • Bone Neoplasms
  • Cell Line, Tumor
  • Osteoclasts
  • Tumor Microenvironment
  • Biomarkers, Tumor
  • Bone Density Conservation Agents
  • Imidazoles

Dr. Weilbaecher's most frequent co-authors

Recent publications by Dr. Weilbaecher

See all 75 publications and co-authors

See who Dr. Weilbaecher researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Weilbaecher works with, so you can find a warm path to the right medical oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Katherine N. Weilbaecher has worked on 8 clinical trials

Dmand AI links Dr. Weilbaecher to 8 clinical trials, 6 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Breast Neoplasms, Breast Diseases and Glioblastoma. Washington University School of Medicine sponsors the most, 8.

Clinical trials with Dr. Weilbaecher by phase

  1. 1Early phase 1: 1 trial
  2. 1Phase 1: 1 trial
  3. 6Phase 2: 6 trials
  4. NonePhase 3: no trials
  5. NonePhase 4: no trials

Conditions in Dr. Weilbaecher's trials

  • Breast Neoplasms
  • Breast Diseases
  • Glioblastoma
  • Neoplasm Metastasis
  • Triple Negative Breast Neoplasms

Investigators on the most trials with Dr. Weilbaecher

Recent clinical trials with Dr. Weilbaecher

See all 8 clinical trials and co-investigators

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Katherine N. Weilbaecher received $613 in industry payments from 2016 to 2023

CMS Open Payments shows 10 general payments to Dr. Weilbaecher from 5 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 100% of the total. Genentech, Inc. paid the most, $236.

General payments to Dr. Weilbaecher by program year, 2016 to 2023

Companies that paid Dr. Weilbaecher the most, 2016 to 2023

Share is of all general payments to this clinician.

See all payments to Dr. Weilbaecher

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Katherine N. Weilbaecher graduated from Stanford University School of Medicine

Dr. Weilbaecher graduated from Stanford University School of Medicine in 1992.

  1. Medical schoolStanford University School of Medicine

Source: Dmand AI Professional Profile Data

Sources for Dr. Katherine N. Weilbaecher's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Affiliation DataDmand AI Practice Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel Data
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Katherine N. Weilbaecher

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Katherine N. Weilbaecher's NPI number?

Dr. Katherine N. Weilbaecher's NPI number is 1447277942. It was assigned on July 17, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Katherine N. Weilbaecher?

Dr. Katherine N. Weilbaecher is a medical oncologist in Saint Louis, Missouri. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).

Where does Dr. Katherine N. Weilbaecher practice?

Dr. Weilbaecher practices at One Barnes-Jewish Hospital Plaza, Saint Louis, MO 63110. Dr. Weilbaecher also practices at 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110. Dr. Weilbaecher's primary practice is Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health. Dmand AI also links Dr. Weilbaecher to 1 group practice or clinic.

What is Dr. Katherine N. Weilbaecher's office phone number?

The practice phone on file for Dr. Weilbaecher is (314) 747-3000.

What is Dr. Katherine N. Weilbaecher's medical license number?

Dr. Weilbaecher holds Missouri license 2000166707.

Which hospitals is Dr. Katherine N. Weilbaecher affiliated with?

Dr. Weilbaecher practices at Barnes-Jewish Hospital in Saint Louis, Missouri. Dr. Weilbaecher is also affiliated with Barnes-Jewish West County Hospital.

What medical group is Dr. Katherine N. Weilbaecher part of?

Dr. Weilbaecher is linked to WashU Medicine Psychiatry.

Does Dr. Katherine N. Weilbaecher accept Medicare?

Yes. CMS data shows Dr. Weilbaecher billed Medicare for 61 services in 2022, and Dr. Weilbaecher accepts Medicare assignment.

What is Dr. Katherine N. Weilbaecher's MIPS score?

Dr. Weilbaecher's MIPS final score for performance year 2024 is 84 out of 100, reported as part of a group.

What services does Dr. Katherine N. Weilbaecher bill to Medicare?

In 2022, Dr. Weilbaecher's most billed Medicare services were surgery: heart and blood vessels (36415) and office visit, established patient (99213).

Show 6 more questionsShow fewer questions

Where did Dr. Katherine N. Weilbaecher go to medical school?

Dr. Weilbaecher graduated from Stanford University School of Medicine in 1992.

What drugs does Dr. Katherine N. Weilbaecher prescribe most?

In 2022 Medicare Part D data, Dr. Weilbaecher's most prescribed drugs by claims were Letrozole.

Has Dr. Katherine N. Weilbaecher received payments from drug or device companies?

CMS Open Payments shows $613 in general payments to Dr. Weilbaecher from 5 companies from 2016 to 2023. The largest total came from Genentech, Inc.

How long has Dr. Katherine N. Weilbaecher been practicing?

Dr. Weilbaecher graduated from medical school in 1992, 34 years ago.

Does Dr. Katherine N. Weilbaecher do research?

Dmand AI links 75 publications to Dr. Weilbaecher, published from 2010 to 2024. Dr. Weilbaecher has worked on 8 clinical trials.

Who does Dr. Katherine N. Weilbaecher publish with?

Dr. Weilbaecher's most frequent co-authors are Foluso Olabisi Ademuyiwa, MD (12 shared papers), Lindsay Leuthen Peterson, MD (9 shared papers) and Rebecca L. Aft, MD (8 shared papers).

Selling to medical oncology practices?

See medical oncologists in Missouri by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)